ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0156

Analysis of Lipidomics and Transcriptomics Reveals the Mechanisms of Cisplatin-Induced Nephrotoxicity in Old Mice

Session Information

  • AKI: Mechanisms - 1
    November 06, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Li, Guoli, Department of Nephrology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China
  • Tan, Huifang, Department of Nephrology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China
  • Xie, Tingting, Department of General Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Chen, Yinyin, Department of Nephrology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China
Background

Clinical studies indicate that elderly patients are more susceptible to cisplatin-induced nephrotoxicity and acute kidney injury (AKI), and have lower long-term survival. However, the exact molecular mechanism underlying remains unclear. The objective of this study was to examine the impact of the cisplatin treatment on the lipidome and transcriptome associated with aging in mouse kidney.

Methods

In this study, we used cisplatin-challenged (20 mg/kg) young C57BL/6 mice (3 months) and aging C57BL/6 mice (24 months) as cisplatin induced AKI models. RNA sequencing and untargeted LC-MS lipidomics was conducted to establish multi-omics signatures of transcriptomic regulation and lipid remodeling.

Results

In total, 4394 lipid species from 44 lipid classes were identified. 374 metabolites were significantly different between young and old group without cisplatin treatment, and 566 metabolites were significantly different between young and old group with cisplatin treatment. Lipidomic analysis shows that aging did not lead to changes of the overall composition of lipid classes. RNA sequencing showed that compare to young mouse kidney, 114 more gene were differentially expressed in old mouse kidney upon cisplatin treatment. These genes involved in pathways, such as arginine biosynthesis, fatty acid biosynthesis, endocrine and other factor−regulated calcium reabsorption and renin−angiotensin system. Integrated transcriptomic and lipidomic analysis identified candidate enzymes responsible for the change of lipid profiles in aged mice. In old mice, a small number of genetic changes caused a strong response to lipid components upon cisplatin treatment.

Conclusion

Our study offers new insights into the molecular mechanisms of aging-related lipid remodeling in the kidney, possibly through which cisplatin induces renal damage. These findings may serve as a comprehensive resource for future studies on cisplatin-induced nephrotoxicity in the setting of aging.

Funding

  • Government Support – Non-U.S.

Digital Object Identifier (DOI)